Sign inJoin waitlistJoin the waitlist

Srikanth Muppidi

Promoted to Clinical Professor of Neurology & Neurological Sciences, Effective September 1, 2023 · Stanford Health Care

Credentials: · · · · ·

History

University of Texas Southwestern Medical Center
2009–2010
Physical Medicine and Rehabilitation
University of Texas Southwestern Medical Center
2008–2009
Neuromuscular Medicine
Thomas Jefferson University Hospital
2007–2008
Neurology
SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
2003–2007
Osmania Medical College
1996–2000

Research

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind,…
The Lancet Neurology · 2017 · 651 citations
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis
Muscle & Nerve · 2019 · First of 21 authors · Corresponding · 192 citations
MG-ADL: still a relevant outcome measure
Muscle & Nerve · 2011 · First of 5 authors · 146 citations

Mitchell Miglis
41 papers · 1 as a resident
James Howard
13 papers
Nicholas Larsen
10 papers · 10 as a fellow
Gil Wolfe
9 papers
Safwan Jaradeh
9 papers
Steven Vernino
9 papers
Richard Nowak
8 papers
Henry Kaminski
6 papers
JG
Jeffrey Guptill
6 papers
Dong-In Sinn
5 papers
JK
John Kissel
4 papers
Mazen Dimachkie
4 papers

Clinical trials

AXIS MG Patient Registry
Study director · Recruiting
Autoimmune Neurology Alliance
2026–2036
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Site PI · Recruiting · Phase 3
Takeda
2025–2028